Avrio MedTech
Avrio MedTech is a French deeptech company commercializing Halyzia®, an AI-powered intracranial EEG visualization and analysis platform for epilepsy research and clinical decision support, serving academic medical centers, hospitals, therapeutic innovators, and EEG equipment providers globally.
- Company typePrivate
- Founded2023
- HeadquartersToulouse, France
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Avrio MedTech does
Avrio MedTech is a French deeptech company founded in August 2023 in Toulouse, commercializing Halyzia®, a software platform for advanced visualization and quantitative analysis of intracranial EEG (iEEG/SEEG) data. The product is built on more than a decade of academic research conducted at CerCo (CNRS), CHU Toulouse, and ENAC, and integrates signal processing, artificial intelligence, and visual analytics to detect epileptic biomarkers — including spikes, ripples (80-200 Hz), and fast ripples (200-600 Hz) — and to compute the Epileptogenicity Index for seizure onset analysis. A core technical differentiator is the patented WALFRID wavelet-based CNN detector for fast-ripples, held under exclusive worldwide rights (PCT/EP2022/079304, US 2024/0398319 A1). Halyzia supports micro/macro electrode recordings up to 32 KHz and combines automatic detection with expert validation workflows and topographic brain mapping.
The company monetizes through three streams: software licensing (subscription/recurring) of Halyzia to research institutions, hospitals and clinics; professional services including quantitative iEEG analysis, custom Clinical Decision Support System development, protocol writing, and project management; and technology integration / white-label modules for EEG equipment providers. Go-to-market combines product-led growth via a free trial download from the website, direct enterprise sales for hospitals and therapeutic innovators, and a channel partnership with FHC Inc. announced in January/February 2025. Customer segments are verticalized: researchers and clinicians (primary), therapeutic innovators (drug developers, neuromodulation, thermo-coagulation), and EEG equipment providers. Named customers and partners include NYU Grossman School of Medicine, CHU de Toulouse, Grenoble University Hospital, CerCo (CNRS), Hôpital Fondation Adolphe de Rothschild, and FHC Inc.
Avrio is a privately held SAS (Société par Actions Simplifiée) with SIREN 978328037, headquartered at the B612 innovation center in Toulouse Aerospace, with an approximately 10-person multidisciplinary team led by co-founders Karine Seymour (CEO, ex-founder of Medexprim), Emmanuel Barbeau (Clinical Lead, CNRS Director of Research), and Christophe Hurter (Data Science Lead, ENAC Professor). To date, funding has been exclusively non-dilutive — Bourse French Tech Emergence (BPI France, 2023), CREALIA Occitanie (2023), DESIRE Eurocluster (2024), and a €75,000 Women TechEU award (January 2025) — with no disclosed institutional venture capital or external revenue figures.
Avrio MedTech firmographics
Firmographics- Name
- Avrio MedTech
- Legal name
- SAS Avrio MedTech
- Website
- https://avriomedtech.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Avrio MedTech is a French deeptech company commercializing Halyzia®, an AI-powered intracranial EEG visualization and analysis platform for epilepsy research and clinical decision support, serving academic medical centers, hospitals, therapeutic innovators, and EEG equipment providers globally.
- Ownership category
- akta.pro rank
Avrio MedTech industry classification
Industry- Product category
- Neurodiagnostic Software
- NAICS
- Computer Systems Design and Related Services (54151)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)
- akta.pro secondary industries
- Epilepsy & Seizure Disorders (HLAKAIAB), SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)
Keywords
Where Avrio MedTech is headquartered
LocationHeadquarters
- HQ city
- Toulouse
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Avrio MedTech business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Software Licensing: Halyzia® software licenses sold to research institutions, hospitals, and clinics. Available for research-use only. Contact-based pricing model.
- Professional Services: Quantitative analysis as a service, custom software development, project management, protocol writing, and clinical site contracting services for iEEG research projects.
- Technology Integration/White-label: Ready-to-integrate modules for EEG equipment providers and therapeutic innovators. Custom development and white-label options available.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Pay-as-you-go | Free Trial - Research evaluation license |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels7 records
Avrio MedTech product offering
Product offeringCore offering
Avrio MedTech develops and sells Halyzia®, a software platform for advanced review and quantitative analysis of intracranial EEG (iEEG/SEEG) recordings. The software combines signal processing, artificial intelligence, and visual analytics to automatically detect epileptic biomarkers (spikes, ripples, fast ripples) and compute the Epileptogenicity Index for seizure onset analysis. It also offers quantitative iEEG analysis services, custom clinical decision support system development, white-label ready-to-integrate modules for EEG equipment providers, and project management services for epilepsy research projects.
Product overview
Avrio MedTech offers Halyzia as its core unified software platform for intracranial EEG (iEEG) quantitative analysis in epilepsy research. The product portfolio includes Halyzia (the main software product), supplemented by professional services such as quantitative iEEG analysis services, custom CDSS development, white-label ready-to-integrate modules for EEG equipment providers, and project management services. The software integrates advanced signal processing, AI-based biomarker detection, and interactive visualization tools.
Differentiator
Problem solved
Functional benefit
Brands
- Halyzia®: Next generation software for advanced review and quantification of intracranial EEG (iEEG) data. Built on more than 10 years of academic research, Halyzia® integrates advanced signal processing, artificial intelligence, advanced visual analytics, and scalable performance for massive datasets. Features include automatic detection of epileptic spikes and high-frequency oscillations (HFOs), seizure onset analysis with Epileptogenicity Index, and topographic mapping capabilities.
Products and services
- Halyzia® A next-generation intracranial EEG (iEEG) visualization and quantification software for advanced review and quantitative analysis of iEEG data. Halyzia enables automatic detection of epileptic biomarkers (spikes, ripples, fast ripples) and seizure onset analysis using the Epileptogenicity Index, with interactive topographic brain mapping. Built on more than 10 years of academic research and integrating advanced signal processing, AI, visual analytics, and scalable performance for massive datasets including micro-electrode recordings at up to 32 KHz. Available for research-use only.
- Quantitative iEEG Analysis Services Expert services including custom iEEG processing pipelines, advanced biomarker extraction, study design and protocol support, data analysis and reporting, and software development and system integration. Services support the full lifecycle from exploratory research to large-scale multicenter studies.
- Clinical Decision Support System (CDSS) Custom Development Custom design and development services for building dedicated Clinical Decision Support Systems for therapeutic innovations. Integrates clinical, imaging, and electrophysiological data with automated pipelines and intuitive interfaces.
- Ready-to-Integrate Modules (White-label) White-label modules for EEG equipment providers offering review and monitoring software in iEEG epilepsy monitoring units, enabling advanced analytics capabilities to be embedded in third-party offerings.
- Project Management Services Comprehensive project management including writing research protocols, sourcing data, contracting with clinical sites, analyzing results, and writing papers for studies involving iEEG signals.
Quantifiable outcome
- 55% of patients remain seizure-free 5 years after epilepsy surgery when analysis enables surgical decision
- +1 more outcomes
Companies that use Avrio MedTech
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles3 records
Avrio MedTech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature7 records
Avrio MedTech partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- FHC Inc.coreAvrio MedTech and FHC Inc. announced a partnership for distribution of Avrio's innovative sEEG analysis software, Halyzia. FHC integrates Halyzia into their portfolio, providing customers with powerful, modern analytical software alongside their world-class EEG hardware. This partnership extends market reach to epileptic monitoring units globally.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Avrio MedTech competitors and assessment
Company assessmentDirect peers
- MICROMED: MICROMED (now part of Bittium) provides EEG acquisition and analysis software used in clinical and research settings. It competes with Halyzia in the intracranial and scalp EEG review/quantification market.
- BESA (BESA GmbH): BESA provides source localization and EEG/MEG analysis software widely used in epilepsy research and clinical neurology. It is comparable to Halyzia as a specialized EEG analysis platform for neuroscience and clinical use.
- ANT Neuro: ANT Neuro provides EEG and MEG acquisition systems plus analysis software used in neuroscience and clinical applications. It competes with Avrio MedTech in the EEG analysis software category.
- Blackrock Microsystems: Blackrock Microsystems manufactures neural recording hardware and offers analysis tools used in intracranial EEG research. It is comparable to Avrio MedTech as a provider serving the iEEG research and clinical neuroscience market.
- Compumedics: Compumedics offers EEG systems including the Curry analysis suite used in clinical epilepsy workflows. It is comparable to Avrio MedTech in serving epilepsy monitoring units with quantitative EEG tools.
- Persyst: Persyst develops automated EEG analysis software (seizure detection, trending, spike detection) used widely in clinical neurology. It is a direct competitor to Halyzia's automated detection capabilities and is now part of Natus Medical.
- Brain Products: Brain Products manufactures EEG hardware and offers BrainVision Analyzer for EEG review. It is comparable to Avrio MedTech in the combined EEG hardware-plus-software workflow serving neuroscience research and clinical customers.
Emerging players
- g.tec medical engineering: g.tec develops brain-computer interface and EEG analysis tools, including real-time signal processing. It overlaps with Halyzia in advanced EEG analysis, with a stronger BCI orientation.
- Wave Neuroscience: Wave Neuroscience applies EEG-based analytics for neurological and psychiatric conditions. It is an emerging player with adjacent, partially overlapping capabilities to Halyzia's quantitative EEG/biomarker focus.
Broad incumbents
- Natus Medical: Natus Medical is a broad incumbent in neurodiagnostics, offering EEG, EMG, and ICU monitoring hardware plus software (including the Persyst acquisition). It is comparable to Avrio MedTech as an established player whose portfolio overlaps with Halyzia's analytics focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Avrio MedTech social profiles
Digital presenceAvrio MedTech compliance and trust
Trust signalCompliance2 records
Avrio MedTech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Avrio MedTech leadership team
Management profileNumber of profiles
Profiles10 records
Avrio MedTech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Avrio MedTech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Avrio MedTech
What does Avrio MedTech do?
Avrio MedTech develops and sells Halyzia®, a software platform for advanced review and quantitative analysis of intracranial EEG (iEEG/SEEG) recordings. The software combines signal processing, artificial intelligence, and visual analytics to automatically detect epileptic biomarkers (spikes, ripples, fast ripples) and compute the Epileptogenicity Index for seizure onset analysis. It also offers quantitative iEEG analysis services, custom clinical decision support system development, white-label ready-to-integrate modules for EEG equipment providers, and project management services for epilepsy research projects.
Is Avrio MedTech a public or private company?
Avrio MedTech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Avrio MedTech founded?
Avrio MedTech was founded in 2023. It employs 11 to 50 people.
Where is Avrio MedTech based?
Avrio MedTech is headquartered in Toulouse, France, in the Europe region.
How does Avrio MedTech make money?
Three revenue lines are on record. Software Licensing is the primary driver. The others are professional Services and technology Integration/White-label.
Who are Avrio MedTech's main competitors?
Direct peers on record are MICROMED, BESA (BESA GmbH), ANT Neuro, Blackrock Microsystems, Compumedics, Persyst and Brain Products. Emerging players are g.tec medical engineering and Wave Neuroscience. Natus Medical is listed as a broad incumbent.
Does Avrio MedTech have an API?
No public API is recorded for Avrio MedTech.
What industry is Avrio MedTech in?
Avrio MedTech's product category is Neurodiagnostic Software. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLAKAIAB, Epilepsy & Seizure Disorders. Its NAICS code is 54151 and its SIC code is 3845.